KIM; Ae Ri

Patent Applications and Registrations

Patent applications and USPTO patent grants for KIM; Ae Ri.The latest application filed is for "coacervate composition containing protein drug and wound healing agent comprising same".

Company Profile

1.5.18

KIM; Ae Ri - Seongnam-si KR
Kim; Ae Ri - King of Prussia PA
KIM; Ae Ri - Daejeon KR
Kim, Ae-Ri - Yuseong-gu KR
Kim, Ae Ri - Deajeon KR
Kim; Ae Ri - Daejon KR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Coacervate Composition Containing Protein Drug And Wound Healing Agent Comprising Same App 20200215232 - KIM; Ae Ri ; et al.	2020-07-09
Stem Cell-derived Skin Precursor Cell Culture Medium And Preparation Method Therefor App 20200157500 - YU; Ji Min ; et al.	2020-05-21
Salt Of Naphthyridine Carboxylic Acid Derivative App 20170253588 - Kim; Ae Ri ; et al.	2017-09-07
Salt Of Naphthyridine Carboxylic Acid Derivative App 20160264569 - Kim; Ae Ri ; et al.	2016-09-15
Salt Of Naphthyridine Carboxylic Acid Derivative App 20150291585 - Kim; Ae Ri ; et al.	2015-10-15
Salt Of Naphthyridine Carboxylic Acid Derivative App 20140187576 - Kim; Ae Ri ; et al.	2014-07-03
Salt Of Naphthyridine Carboxylic Acid Derivative App 20130065917 - KIM; Ae Ri ; et al.	2013-03-14
Salt Of Naphthyridine Carboxylic Acid Derivative App 20110312987 - Kim; Ae Ri ; et al.	2011-12-22
Salt Of Naphthyridine Carboxylic Acid Derivative App 20100240694 - KIM; Ae Ri ; et al.	2010-09-23
Salt of naphthyridine carboxylic acid derivative Grant 7,700,617 - Kim , et al. April 20, 2	2010-04-20
Salt of naphthyridine carboxylic acid derivative App 20090182006 - Kim; Ae Ri ; et al.	2009-07-16
Caspase inhibitors containing isoxazoline ring Grant 7,557,133 - Chang , et al. July 7, 2	2009-07-07
Salt of naphthyridine carboxylic acid derivative App 20080039488 - Kim; Ae Ri ; et al.	2008-02-14
Caspase inhibitors containing isoxazoline ring App 20060223848 - Chang; Hye-Kyung ; et al.	2006-10-05
Orally administrable pharmaceutical compositions and methods for preventing food-drug interaction App 20040229821 - Kim, Ae-Ri ; et al.	2004-11-18
Salt of naphthyridine carboxylic acid derivative App 20040198767 - Kim, Ae Ri ; et al.	2004-10-07
Salt of naphthyridine carboxylic acid derivative Grant 6,723,734 - Kim , et al. April 20, 2	2004-04-20
Salt of naphthyridine carboxylic acid derivative App 20030050321 - Kim, Ae Ri ; et al.	2003-03-13
Salt of naphthyridine carboxylic acid derivative App 20020032216 - Kim, Ae Ri ; et al.	2002-03-14
7-(4-aminomethyl-3-me thyloxyiminopyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8 -naphthyridine-3-carboxylic acid and the process for the preparation thereof Grant 5,869,670 - Hong , et al. February 9, 1	1999-02-09
Sustained release formulation of animal growth hormone and process for preparation thereof Grant 5,744,163 - Kim , et al. April 28, 1	1998-04-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.